Summary |
|
||||||||
Variant origin |
|
||||||||
Variant description |
|
||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:109827Linkage analysis was performed on 13 AcB and 22 BcA (A=A/J; B=C57BL/6J) recombinant congenic (RC) strains to identify QTL associated with sensitivity to nicotine-induced locomotor activity. A panel of 625 polymorphic markers at an average resolution of 2.6 cMwas used for the genome scan. Parental strain C57BL/6J is insensitive to nicotine-induced locomotor activity whereas parental strain A/J exhibits reduced activity after nicotine administration. QTL reaching statistical significance of P<0.01 are described below. In the BcA RC lines, linkage to nicotine-induced locomotor activity mapped to 14 cM at peak marker D11Mit82 and to 49 cM with peak marker D11Mit39 on mouse Chromosome 11. These loci are named Nilac1 (nicotine induced locomotor activity 1) and Nilac2, respectively. The Nilac1 QTL interval spans 1.5 cM to 18 cM. Potential candidate genes near this region are Gabra1 (19 cM) and Gabra6 (23 cM). C57BL/6J-derived alleles at Nilac1 confer increased locomotor activity. The Nilac2 QTL interval spans47.67 cM to 54 cM. Lore4(49 cM) is an ethanol sensitivity QTL mapping near Nilac2. C57BL/6J-derived alleles at Nilac2 confer decreased locomotor activity after nicotine administration.In the AcB RC lines, Nilac3 (nicotine induced locomotor activity 3) mapped to 83.1 cM on mouse Chromosome 2 with peak marker D2Mit311. The QTL interval spans 71 cM to 96 cM. A/J-derived alleles at Nilac3 confer increased locomotor activity after nicotine administration. Sstr4 at 84 cM is a potential candidate gene for Nilac2. In the AcB RC lines, Nilac4 (nicotine induced locomotor activity 4) maps to 57.5 cM on mouse Chromosome 7 with peak marker D7Mit66. The QTL interval spans 57.5 to 66.6 cM. A/J-derived alleles at Nilac4 confer increased locomotor activity after nicotine administration. In the AcB RC lines, Nilac5 (nicotine induced locomotor activity 5) maps to 6 cM on mouse Chromosome 8 with peak marker D8Mit124. A/J-derived alleles at Nilac5 confer increased locomotor activity after nicotine administration.In the AcB RC lines, linkage to nicotine sensitivity mapped to 16 cM on mouse Chromosome 13 with peak marker D13Mit59. This locus is named Nilac6 (nicotine induced locomotor activity 6). The QTL interval spans 16 cM to 21 cM. A/J-derived alleles at Nilac6 confer increasedlocomotor activity after nicotineadministration. In the BcARC lines, linkage to nicotine sensitivity mapped to 9 cM near D13Mit218. This locus is named Nilac7. The QTL interval spans 8 cM to 11 cM. C57BL/6J-derived alleles at Nilac7 confer increased locomotor activation after nicotine administration.In the AcBRC lines, Nilac8 (nicotine induced locomotor activity 8) maps to 25 cM on mouse Chromosome 14 with peak marker D14Mit155. A/J-derived alleles at Nilac8 confer increased locomotor activity after nicotine administration. In the BcA RClines, linkage to nicotine sensitivity mapped to 52 cM with peak marker D14Mit165. This locus is named Nilac9. The QTL interval spans 52 cM to 60 cM. C57BL/6J-derived alleles at Nilac9 confer increased locomotor activityafter nicotine administration. Inthe AcB RC lines, Nilac10 (nicotine inducedlocomotor activity 10) maps to 4.3 cM on mouse Chromosome 16 to peak marker D16Mit131. The QTL range spans 4.3 cM to 66 cM. A/J-derived alleles at Nilac10 confer increased locomotor activity after nicotine administration.Drd3 at 23.3 cM is a potential candidate gene for Nilac10.In the BcA RC lines, Nilac11 (nicotine induced locomotor activity 11) maps to 56.7 cM on mouse Chromosome 17 with peak marker D17Mit221.C57BL/6J-derived alleles at Nilac11 confer increased locomotor activity after nicotine administration. Nilac12 was detected in the AcB RC lines and overlaps with Nilac11. This locus peaks at 54.6 cM with marker D17Mit76. The QTL interval spans 44.5 cM to56 cM. A/J-derived alleles at Nilac12 confers increased locomotor activity after nicotine administration. |
||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|